°¡»ó ÀÓ»ó½ÃÇè ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ ¹× »ê¾÷ ºÐ¼® º¸°í¼­ : ¼³°èº°, ÀûÀÀÁõº°, ´Ü°èº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)
Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032
»óǰÄÚµå : 1339319
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 118 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,149,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 285¾ï 4,408¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¿¬±¸°³¹ß Ȱµ¿ Áõ°¡, ÇコÄɾîÀÇ µðÁöÅÐÈ­, ¿ø°ÝÀÇ·áÀÇ µµÀÔÀÌ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÀÓ»ó½ÃÇè¿¡¼­ °¡»ó ÀÓ»ó½ÃÇè, ¿ø°Ý Âü¿© ¹× ¸ð´ÏÅ͸µÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. Á¶Á÷ °£ Çù·Â°ú Á¤ºÎÀÇ Áö¿øÃ¥µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÀÓ»ó½ÃÇèÀÇ À¯¿¬¼º, È¿À²¼º, ȯÀÚ Âü¿©µµ¸¦ Çâ»ó½ÃŰ´Â °¡»ó ¹æ½Ä¿¡ ´ëÇÑ ¾÷°èÀÇ ÁýÁßÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

Äڷγª19´Â ÀÓ»ó½ÃÇè¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, °¡»ó ÀÓ»ó½ÃÇèÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ ¸ðÁý°ú À¯Áö¿¡ ¾î·Á¿òÀ» °ÞÀ¸¸é¼­ ÁøÇà ÁßÀÎ ÀÓ»ó½ÃÇè¿¡ Â÷ÁúÀÌ »ý°å½À´Ï´Ù. °¡»ó ÀÓ»ó½ÃÇèÀº ÆÒµ¥¹Í »óȲ¿¡¼­ Áß¿äÇÑ ÇØ°áÃ¥À¸·Î µîÀåÇÏ¿© Âü°¡ÀÚµéÀÌ Áý¿¡¼­ Âü¿©ÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ÇöÀå ¹æ¹®ÀÌ ºÒ°¡´ÉÇÑ »óȲ¿¡¼­µµ ¿¬±¸ÀÇ ¿¬¼Ó¼ºÀ» º¸ÀåÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

°¡»ó ÀÓ»ó½ÃÇèÀº ¿ø°Ý µ¥ÀÌÅÍ ¼öÁý, Âü°¡ÀÚ Âü¿©µµ Çâ»ó, ´õ Å« ±Ô¸ðÀÇ Áý´Ü Âü¿© µî ¸¹Àº ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. Á÷Á¢ ¹æ¹®¿¡ µû¸¥ À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí Âü°¡ÀÚ, ÄÚµð³×ÀÌÅÍ, ÀÓ»ó½ÃÇè Ã¥ÀÓÀÚÀÇ ºÎ´ãÀ» ÁÙ¿©ÁÝ´Ï´Ù. °¡»ó ±â¼úÀ» Ȱ¿ëÇϸé ÀÓ»ó½ÃÇè ¾÷°è°¡ Á÷¸éÇÑ ¹®Á¦¸¦ ±Øº¹Çϰí, È¿À²¼ºÀ» ³ôÀ̰í, ½Å¼ÓÇϰí È¿°úÀûÀÎ µ¥ÀÌÅÍ ¼öÁýÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

°¡»ó ÀÓ»ó½ÃÇè ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2022³â, Çõ½ÅÀûÀÎ ¾à¹°¿¡ ´ëÇÑ ¼ö¿ä¿Í ½ÃÀå ¼¼ºÐÈ­ÀÇ À¯Çà¿¡ µû¸¥ ½ÃÇè ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÁßÀç ¼³°è ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù.

¾Ï ºÎ¹®Àº 2022³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¾Ï ¹ßº´·ü Áõ°¡¿Í Äڷγª19 ÆÒµ¥¹Í ±â°£ µ¿¾È ȯÀÚ ¾ÈÀüÀ» À§ÇÑ °¡»ó ½ÃÇèÀÇ Ã¤ÅÃÀ¸·Î ÀÎÇØ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÏ¹Ì´Â ´ëÇü Á¦¾à»ç, Á¤ºÎ ÅõÀÚ, ¾á¼¾°ú PRA Health SciencesÀÇ ½ÉºÎÀü ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ºÐ»êÇü Ä«³ª±Û¸®Ç÷ÎÁø ½ÃÇè°ú °°Àº °øµ¿ ¿¬±¸·Î ÀÎÇØ ¼¼°è °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå¿¡¼­ Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå, ¼³°èº°

Á¦6Àå ¼¼°èÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå, ÀûÀÀÁõº°

Á¦7Àå ¼¼°èÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå, ´Ü°èº°

Á¦8Àå ¼¼°èÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå, Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global virtual clinical trials market size is expected to reach USD 28,544.08 million by 2032, according to a new study by Polaris Market Research. The report "Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased research and development activities, healthcare digitization, and the adoption of telehealth drive the virtual clinical trials market. These factors enable seamless integration of virtual trials, remote participation, and monitoring in clinical studies. Collaborations between organizations and supportive government initiatives contribute to the market's growth. These trends emphasize the industry's focus on virtual methods, which offer flexibility, efficiency, and improved patient engagement in clinical trials.

The COVID-19 pandemic has profoundly impacted clinical trials, leading to increased adoption of virtual trials. Challenges in patient recruitment and retention have been observed, and disruptions to ongoing trials have occurred. Virtual trials emerged as a crucial solution during the pandemic, allowing participants to participate from home and ensuring research continuity when site visits were impossible.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Virtual Clinical Trials Market Report Highlights

The interventional design segment dominated the market in 2022, driven by the need for innovative medications and the increased demand for trials amidst the COVID-19 pandemic.

The oncology segment led the market in 2022 and is expected to maintain its dominance due to the rising incidence of cancer and the adoption of virtual trials for patient safety during the COVID-19 pandemic.

North America holds a significant revenue share in the global virtual clinical trials market, driven by major pharmaceutical companies, government investments, and collaborations like Janssen and PRA Health Sciences' decentralized Canagliflozin study for heart failure patients.

The global key market players include: LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Medable, Inc., Paraxel International, Clinical Ink, Inc., PRA Health Sciences, Science 37, and ICON plc.

Polaris Market Research has segmented the Virtual Clinical Trials market report based on design, indication, phases, and region:

Virtual Clinical Trials, Design Outlook (Revenue - USD Million, 2019 - 2032)

Virtual Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)

Virtual Clinical Trials, Phases Outlook (Revenue - USD Million, 2019 - 2032)

Virtual Clinical Trials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Virtual Clinical Trials Market Insights

5. Global Virtual Clinical Trials Market, by Design

6. Global Virtual Clinical Trials Market, by Indication

7. Global Virtual Clinical Trials Market, by Phases

8. Global Virtual Clinical Trials Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â